Search research articles
Contact Us
Filters
Showing results (111-120 of 122) with videos related to
Page
of 13
Sort By:
Plos One
|
May 13, 2015
SP-R210 (Myo18A) Isoforms as Intrinsic Modulators of Macrophage Priming and Activation
Linlin Yang, Marykate Carrillo, Yuchieh M Wu, et al.
Journal of Virology
|
August 3, 2022
Passive Immunization with a Single Monoclonal Neutralizing Antibody Protects against Cutaneous and Mucosal Mouse Papillomavirus Infections
Sarah A Brendle, Jingwei Li, Nancy M Cladel, et al.
Journal of Pharmaceutical Sciences
|
December 3, 2022
Multi-dose Formulation Development for a Quadrivalent Human Papillomavirus Virus-Like Particle-Based Vaccine: Part II- Real-time and Accelerated Stability Studies
Nitya Sharma, Kaushal Jerajani, Ying Wan, et al.
Elife
|
September 17, 2020
Antibody escape by polyomavirus capsid mutation facilitates neurovirulence
Matthew D Lauver, Daniel J Goetschius, Colleen S Netherby-Winslow, et al.
Chemico-Biological Interactions
|
November 13, 2020
The environmental pollutant and tobacco smoke constituent dibenzo[def,p]chrysene is a co-factor for malignant progression of mouse oral papillomavirus infections
Neil D Christensen, Kun-Ming Chen, Jiafen Hu, et al.
Journal of Pharmaceutical Sciences
|
September 12, 2022
Multi-Dose Formulation Development for a Quadrivalent Human Papillomavirus Virus-Like Particle-Based Vaccine: Part I - Screening of Preservative Combinations
Kaushal Jerajani, Ying Wan, Ozan S Kumru, et al.
Antiviral Research
|
April 14, 2018
BET bromodomain inhibitors show anti-papillomavirus activity in vitro and block CRPV wart growth in vivo
Mary A Morse, Karla K Balogh, Sarah A Brendle, et al.
Journal of Pharmaceutical Sciences
|
August 1, 2022
Analytical and Preformulation Characterization Studies of Human Papillomavirus Virus-Like Particles to Enable Quadrivalent Multi-Dose Vaccine Formulation Development
Kaushal Jerajani, Ying Wan, John M Hickey, et al.
Emerging Microbes & Infections
|
July 26, 2019
Papillomavirus can be transmitted through the blood and produce infections in blood recipients: Evidence from two animal models
Nancy M Cladel, Pengfei Jiang, Jingwei J Li, et al.
Mbio
|
July 16, 2024
Monitoring mouse papillomavirus-associated cancer development using longitudinal Pap smear screening
Hannah M Atkins, Aysegul Aksakal Uslu, Jingwei J Li, et al.
Page
of 13
Search research articles
Search
Showing results (111-120 of 122) with videos related to
Sort By:
Page
of 13
Plos One
|
May 13, 2015
SP-R210 (Myo18A) Isoforms as Intrinsic Modulators of Macrophage Priming and Activation
Linlin Yang, Marykate Carrillo, Yuchieh M Wu, et al.
Journal of Virology
|
August 3, 2022
Passive Immunization with a Single Monoclonal Neutralizing Antibody Protects against Cutaneous and Mucosal Mouse Papillomavirus Infections
Sarah A Brendle, Jingwei Li, Nancy M Cladel, et al.
Journal of Pharmaceutical Sciences
|
December 3, 2022
Multi-dose Formulation Development for a Quadrivalent Human Papillomavirus Virus-Like Particle-Based Vaccine: Part II- Real-time and Accelerated Stability Studies
Nitya Sharma, Kaushal Jerajani, Ying Wan, et al.
Elife
|
September 17, 2020
Antibody escape by polyomavirus capsid mutation facilitates neurovirulence
Matthew D Lauver, Daniel J Goetschius, Colleen S Netherby-Winslow, et al.
Chemico-Biological Interactions
|
November 13, 2020
The environmental pollutant and tobacco smoke constituent dibenzo[def,p]chrysene is a co-factor for malignant progression of mouse oral papillomavirus infections
Neil D Christensen, Kun-Ming Chen, Jiafen Hu, et al.
Journal of Pharmaceutical Sciences
|
September 12, 2022
Multi-Dose Formulation Development for a Quadrivalent Human Papillomavirus Virus-Like Particle-Based Vaccine: Part I - Screening of Preservative Combinations
Kaushal Jerajani, Ying Wan, Ozan S Kumru, et al.
Antiviral Research
|
April 14, 2018
BET bromodomain inhibitors show anti-papillomavirus activity in vitro and block CRPV wart growth in vivo
Mary A Morse, Karla K Balogh, Sarah A Brendle, et al.
Journal of Pharmaceutical Sciences
|
August 1, 2022
Analytical and Preformulation Characterization Studies of Human Papillomavirus Virus-Like Particles to Enable Quadrivalent Multi-Dose Vaccine Formulation Development
Kaushal Jerajani, Ying Wan, John M Hickey, et al.
Emerging Microbes & Infections
|
July 26, 2019
Papillomavirus can be transmitted through the blood and produce infections in blood recipients: Evidence from two animal models
Nancy M Cladel, Pengfei Jiang, Jingwei J Li, et al.
Mbio
|
July 16, 2024
Monitoring mouse papillomavirus-associated cancer development using longitudinal Pap smear screening
Hannah M Atkins, Aysegul Aksakal Uslu, Jingwei J Li, et al.
Page
of 13